Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$3.64 - $7.76 $1,820 - $3,880
-500 Closed
0 $0
Q1 2020

Apr 14, 2020

SELL
$4.0 - $21.53 $2,400 - $12,918
-600 Reduced 54.55%
500 $2,000
Q4 2019

Feb 24, 2020

BUY
$13.94 - $24.12 $11,110 - $19,223
797 Added 263.04%
1,100 $24,000
Q3 2019

Oct 29, 2019

BUY
$13.89 - $23.16 $4,208 - $7,017
303 New
303 $5,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $246M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Ima Wealth, Inc. Portfolio

Follow Ima Wealth, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ima Wealth, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ima Wealth, Inc. with notifications on news.